title: Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation.
authors.affiliation: Thomas E. Starzl Transplantation Institute, Pittsburgh, PA 15261, USA.
authors.forename: T
authors.initials: T
authors.lastname: Miki
authors.forename: A
authors.initials: A
authors.lastname: Goller
authors.forename: A
authors.initials: A
authors.lastname: Rao
authors.forename: X
authors.initials: X
authors.lastname: Wang
authors.forename: W Y
authors.initials: WY
authors.lastname: Yin
authors.forename: A
authors.initials: A
authors.lastname: Tandin
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
authors.forename: L A
authors.initials: LA
authors.lastname: Valdivia
mesh_terms: D000818:Animals; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004357:Drug Synergism; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D006168:Guinea Pigs; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007555:Isoxazoles / Q000627:therapeutic use*; D000077339:Leflunomide; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D051381:Rats; D011917:Rats, Inbred Lew; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000401:mortality
chemical_list: D007166:Immunosuppressive Agents; D007555:Isoxazoles; D003520:Cyclophosphamide; D000077339:Leflunomide; D009173:Mycophenolic Acid; D016559:Tacrolimus